Pulmonary alveolar proteinosis associated with psoriasis and complicated by mycobacterial infection: Successful treatment with granulocyte-macrophage colony stimulating factor after a partial response to whole lung lavage-Reference-Cited by-同舟云学术

Pulmonary alveolar proteinosis associated with psoriasis and complicated by mycobacterial infection: Successful treatment with granulocyte-macrophage colony stimulating factor after a partial response to whole lung lavage

Published:2004-08 Issue:3 Volume:9 Page:419-422
ISSN:1323-7799
Container-title:Respirology
language:en
Short-container-title:Respirology

Author:

ABDUL RAHMAN Jamalul Azizi,MOODLEY Yuben P.,PHILLIPS Martin J.

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1440-1843.2004.00594.x/fullpdf

Reference18 articles.

1. Pulmonary Alveolar Proteinosis in Association with Fanconi’s Anemia and Psoriasis

2. Pulmonary alveolar proteinosis

3. Role of Growth Factors, Cytokines, and Their Receptors in the Pathogenesis of Psoriasis

4. Response of Psoriasis to Interleukin-10 is Associated with Suppression of Cutaneous Type 1 Inflammation, Downregulation of the Epidermal Interleukin-8/CXCR2 Pathway and Normalization of Keratinocyte Maturation

5. GM-CSF Gene Expression Is Normal but Protein Release Is Absent in a Patient with Pulmonary Alveolar Proteinosis

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of alpha‐1‐antitrypsin (AAT)‐regulated, glucocorticoid receptor‐dependent genes in macrophages reveals a novel host defense function of AAT;Physiological Reports;2024-07

2. Anti-Interferon Autoantibodies in Adult-Onset Immunodeficiency Syndrome and Severe COVID-19 Infection;Frontiers in Immunology;2021-12-22

3. Personalised Medicine for Tuberculosis and Non-Tuberculous Mycobacterial Pulmonary Disease;Microorganisms;2021-10-26

4. Revisiting John Snow to Meet the Challenge of Nontuberculous Mycobacterial Lung Disease;International Journal of Environmental Research and Public Health;2019-11-01

5. Vulnerability to Nontuberculous Mycobacterial Lung Disease or Systemic Infection Due to Genetic/Heritable Disorders;Nontuberculous Mycobacterial Disease;2018-10-06